Ir al contenido

Cesta

La cesta está vacía

Seguir comprando
Model_ReleafGelSM_2
Clínica

Clínicamente probado: una alternativa segura a las cremas con esteroides

Our formula was studied in patients with moderate-to-severe atopic dermatitis and published in Dermatological Reviews (Wiley, 2025).

Published research

Dermatological Reviews · Wiley · Vol. 6, Issue 2 · March 2025

Improvement in Atopic Dermatitis Using a Novel Topical 2% Cannabidiol (CBD) Application

Sarah Hakim, Sanjeev Goel, John Papastergiou, David J. Goldberg

Phoilex Ltd., Toronto · Peak Human Health, Brampton · Skin Laser & Surgery Specialists, a Division of Schweiger Dermatology, New York

  • Peer-reviewed journal
  • Clinician-examined
  • Moderate-to-severe atopic dermatitis
  • Clinical photography
Read the full study
Cite this study

Hakim S, Goel S, Papastergiou J, Goldberg DJ. Improvement in Atopic Dermatitis Using a Novel Topical 2% Cannabidiol (CBD) Application. Dermatological Reviews. 2025;6(2). doi:10.1002/der2.70024

DOI: 10.1002/der2.70024

The study at a glance

19patients with moderate-to-severe atopic dermatitis
5clinical visits: baseline, weeks 1, 2, 4 and 8
2outcomes: lesion appearance and patient satisfaction
0steroids in the formula

Prospective, open-label pilot cohort. Lesions were assessed with objective evaluations and clinical photography, which were consistent with patient-reported improvement. Individual results vary.

More than a cosmetic test

Many skincare claims come from short consumer surveys. Ours went through a clinical study and independent peer review.

Typical cosmetic testingThe Phoilex study
Who took partVolunteers, often without a diagnosisPatients with moderate-to-severe atopic dermatitis
Who judged resultsSelf-reported questionnairesClinicians, with objective evaluations and clinical photography
Follow-upOften a single use or a short trialFive visits over 8 weeks
ScrutinyUsually internal and unpublishedPeer-reviewed and published, with a permanent DOI

100%

de los participantes dijeron que seguirán utilizando el gel localizado ReLeaf en el futuro

74%

Los participantes documentaron haber visto una reducción del 74% en el número de brotes

83%

Sentían que su zona irritada de la piel estaba calmada y reconfortada

From the study investigator

“I’m encouraged by the results demonstrating that Phoilex products provide a safe, effective, and steroid-free alternative for patients living with atopic dermatitis and other chronic skin conditions.”
Dr. John Papastergiou, BScPhm, PhD, RPh · Study author

What clinicians say

Independent reviews from verified clinicians on FrontrowMD.

For healthcare professionals

Recommend it with confidence

Dermatology clinics, pharmacies and med spas: request professional pricing, samples and the full paper for your team.

AthenaRangel

Durante los meses de invierno y verano, mis manos y pies sufren mucha sequedad. Es muy difícil encontrar una crema que ayude a mi piel. Usando Phoilex, mi piel absorbió el gel de alivio localizado activo y ha hidratado mi piel. Ha ayudado con la sequedad que experimento.

Kat A.

¡Este producto es mi salvación! Desaparece mis brotes en menos de 24 horas. Proporciona mucho alivio y calma casi instantáneamente la picazón, el ardor y el dolor. ¡Lo recomiendo 10/10!

Try what the study tested

New to Phoilex? Start with the $8 Mini, or choose Subscribe & Save: it renews automatically on your schedule and you can skip, pause or cancel anytime online.

Shop steroid-free